In addition, large-scale epidemiological studies have demonstrated the association of the FTO SNP risk genotype with the development of cancers such as breast, kidney, prostate, and pancreatic cancers, as well as leukemia, lymphoma and myeloma (Soderberg et al. 2009; Li et al. 2012; Hernandez-Caballero and Sierra-Ramirez 2015). This evidence concerns the gene FTO and cancer.